Resistance to Key Malaria Drug Detected in African Children

A study reveals partial resistance to artemisinin in Ugandan children with severe malaria, raising concerns over treatment efficacy.

Researchers found that 11% of Ugandan children with severe malaria showed partial resistance to artemisinin, a crucial drug.
The study involved 100 children hospitalized with severe malaria, revealing genetic mutations linked to drug resistance.
Partial resistance was identified for the first time in African children with severe malaria, a group highly vulnerable to the disease.
10 children experienced a recurrence of malaria, suggesting possible resistance to the partner drug lumefantrine.
Experts warn that if resistance spreads, it could significantly impact malaria treatment guidelines and increase mortality rates.